Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Fairbanks, L.D.
Right arrow Articles by Cameron, J.S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fairbanks, L.D.
Right arrow Articles by Cameron, J.S.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Q J Med 2004; 97: 106-107
© Association of Physicians 2004; all rights reserved.

Correspondence

Familial juvenile hyperuricaemic nephropathy

The first 10% of the full text of this article appears below.

Sir,

The letter of Bleyer et al.1 raised two important questions regarding our families reported in QJM,2 with the syndrome termed familial juvenile hyperuricaemic nephropathy (FJHN). The first was the questionable efficacy of allopurinol, in view of its lack of effect in ameliorating the progression of the renal lesion in the single large kindred they reported recently,3 and second, whether similar uromodulin mutations are responsible . . . [Full Text of this Article]

L.D. Fairbanks, A.M. Marinaki, H.A. Simmonds and J.S. Cameron

Purine Research Renal Unit Guy's Hospital London e-mail: lynette.fairbanks@kcl.ac.uk


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?